Glycaemic Control of Weekly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes

Name: Glycaemic Control of Weekly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes
Published: 2014
License: Public Domain

Hanmi Pharmaceutical Company Limited · 2014

ClinicalTrials.gov · Datasets · License: Public Domain · 2014

Open Source ↗

efficacy glucagon likepeptide placebo safety type2diabetes type2diabetesmellitus

type 2 diabetes, glycaemic control, hm11260c, placebo, safety, tolerability, type 2 diabetes mellitus, efficacy, t2dm, glycated haemoglobin (hba1c), glycosylated haemoglobin (hba1c), glucagon-like peptide-1 (glp-1) agonists

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 834903
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.